Evidence map›Paper›PMID 37349292›Full record

ArticleNature communications2023

Predicting in-hospital outcomes of patients with acute kidney injury.

Changwei Wu, Yun Zhang, Sheng Nie, Daqing Hong, Jiajing Zhu, Zhi Chen, Bicheng Liu, Huafeng Liu, Qiongqiong Yang, Hua Li and 17 more

Abstract readMulticenter Study
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Temporal Recurrent Neural Networks for Predicting Acute Kidney Injury Recovery by Time of Discharge.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2026
    Article
  12. Review
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. PANoptosis: A novel therapeutic target in kidney disease (Review).International journal of molecular medicine · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Changwei Wu *Department of Nephrology and Nephrology Institute, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, 610072, Chengdu, China.
Yun Zhang *Knowledge and Data Engineering Laboratory of Chinese Medicine, School of Information and Software Engineering, University of Electronic Science and Technology of China, 610054, Chengdu, China.
Sheng Nie *National Clinical Research Center for Kidney Disease, State Laboratory of Organ Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, 510515, Guangzhou, China.
Daqing HongDepartment of Nephrology and Nephrology Institute, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, 610072, Chengdu, China.
Jiajing ZhuKnowledge and Data Engineering Laboratory of Chinese Medicine, School of Information and Software Engineering, University of Electronic Science and Technology of China, 610054, Chengdu, China.
Zhi ChenKnowledge and Data Engineering Laboratory of Chinese Medicine, School of Information and Software Engineering, University of Electronic Science and Technology of China, 610054, Chengdu, China.
Bicheng LiuInstitute of Nephrology, Zhongda Hospital, Southeast University School of Medicine, 210000, Nanjing, China.ORCID 0000-0002-4584-1853
Huafeng LiuKey Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, 524000, Zhanjiang, China.
Qiongqiong YangDepartment of Nephrology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 510515, Guangzhou, China.
Hua LiSir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310000, Hangzhou, China.
Gang XuDivision of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430000, Wuhan, China.
Jianping WengDepartment of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, 230000, Hefei, China.
Yaozhong KongDepartment of Nephrology, the First People's Hospital of Foshan, 528000, Foshan, China.
Qijun WanThe Second People's Hospital of Shenzhen, Shenzhen University, 518000, Shenzhen, China.
Yan ZhaGuizhou Provincial People's Hospital, Guizhou University, 550000, Guiyang, China.
Chunbo ChenDepartment of Critical Care Medicine, Maoming People's Hospital, 525000, Maoming, China.ORCID 0000-0001-5662-497X
Hong XuChildren's Hospital of Fudan University, 200000, Shanghai, China.
Ying HuThe Second Affiliated Hospital of Zhejiang University School of Medicine, 310000, Hangzhou, China.
Yongjun ShiHuizhou Municipal Central Hospital, Sun Yat-Sen University, 516000, Huizhou, China.
Yilun ZhouDepartment of Nephrology, Beijing Tiantan Hospital, Capital Medical University, 100000, Beijing, China.
Guobin SuDepartment of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital, The Second Clinical College, Guangzhou University of Chinese Medicine, 510000, Guangzhou, China.
Ying TangThe Third Affiliated Hospital of Southern Medical University, 510000, Guangzhou, China.ORCID 0000-0003-0777-5565
Mengchun GongInstitute of Health Management, Southern Medical University, 510000, Guangzhou, China.ORCID 0000-0001-8197-6643
Li WangDepartment of Nephrology and Nephrology Institute, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, 610072, Chengdu, China.
Fanfan HouNational Clinical Research Center for Kidney Disease, State Laboratory of Organ Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, 510515, Guangzhou, China. ffhouguangzhou@163.com.ORCID 0000-0003-3117-7418
Yongguo LiuKnowledge and Data Engineering Laboratory of Chinese Medicine, School of Information and Software Engineering, University of Electronic Science and Technology of China, 610054, Chengdu, China. ygliu_uestc@163.com.ORCID 0000-0002-4906-7025
Guisen LiDepartment of Nephrology and Nephrology Institute, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, 610072, Chengdu, China. guisenli@163.com.ORCID 0000-0003-1970-9979

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) is prevalent and a leading cause of in-hospital death worldwide. Early prediction of AKI-related clinical events and timely intervention for high-risk patients could improve outcomes. We develop a deep learning model based on a nationwide multicenter cooperative network across China that includes 7,084,339 hospitalized patients, to dynamically predict the risk of in-hospital death (primary outcome) and dialysis (secondary outcome) for patients who developed AKI during hospitalization. A total of 137,084 eligible patients with AKI constitute the analysis set. In the derivation cohort, the area under the receiver operator curve (AUROC) for 24-h, 48-h, 72-h, and 7-day death are 95·05%, 94·23%, 93·53%, and 93·09%, respectively. For dialysis outcome, the AUROC of each time span are 88·32%, 83·31%, 83·20%, and 77·99%, respectively. The predictive performance is consistent in both internal and external validation cohorts. The model can predict important outcomes of patients with AKI, which could be helpful for the early management of AKI.

Indexed as

Acute Kidney InjuryRenal DialysisHospital MortalityHospitalsHumansRetrospective StudiesRisk Factors

Identifiers

PMID37349292
PMCPMC10287760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.